Charles E. Grier
Impact in
-
- Colorectal Cancer Treatments and Studies
- PARP inhibition in cancer therapy
-
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
-
- Glycosylation and Glycoproteins Research 2
- Ion Transport and Channel Regulation 1
-
- Prostate Cancer Diagnosis and Treatment 2
- Co-authors
- Rajesh Kaldate (5 shared papers)Stephanie A. Hamilton (4 shared papers)Andrea M. Mastro (4 shared papers)Abebe Haregewoin (3 shared papers)Howard L. McLeod (1 shared paper)John F. Sandbach (1 shared paper)Mark A. Silberman (1 shared paper)Anne‐Renee Hartman (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)The Oncologist (1 paper)Clinical Therapeutics (1 paper)Journal of Leukocyte Biology (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- United StatesGermanyIndia
In The Last Decade
Charles E. Grier
12 papers receiving 375 citations
Peers
Comparison fields: 5 of 64
- Oncology 136
- Cancer Research 75
- Pulmonary and Respiratory Medicine 89
- Genetics 75
- Urology 11
Countries citing papers authored by Charles E. Grier
This map shows the geographic impact of Charles E. Grier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Grier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Grier more than expected).
Fields of papers citing papers by Charles E. Grier
This network shows the impact of papers produced by Charles E. Grier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Grier. The network helps show where Charles E. Grier may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles E. Grier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 159 | |
| 2 | 2012 | 76 | |
| 3 | 2015 | 56 | |
| 4 | 1985 | 26 | |
| 5 | 1996 | 15 | |
| 6 | 1988 | 14 | |
| 7 | 1989 | 10 | |
| 8 | 1986 | 9 | |
| 9 | 1989 | 8 | |
| 10 | 2012 | 3 | |
| 11 | Negative regulation of interleukin-2 production in primary lymphocytes by 12-O-tetradecanoylphorbol-13-acetate. | 1991 | 3 |
| 12 | 2012 | 2 |
About Charles E. Grier
Charles E. Grier is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Social Psychology and Surgery, having authored 12 papers that have together received 381 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (3 papers), Glycosylation and Glycoproteins Research (2 papers), Neuroendocrine regulation and behavior (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Circadian rhythm and melatonin (1 paper), Pharmacological Effects of Natural Compounds (1 paper), Ion Transport and Channel Regulation (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Oncology (136 citations), Cancer Research (75 citations), Pulmonary and Respiratory Medicine (89 citations), Genetics (75 citations) and Urology (11 citations). Charles E. Grier has collaborated with scholars based in United States, Germany and India. Frequent co-authors include Rajesh Kaldate, Stephanie A. Hamilton, Andrea M. Mastro, Abebe Haregewoin, Howard L. McLeod, John F. Sandbach, Mark A. Silberman, Anne‐Renee Hartman, Lisa Painter and Cynthia Frye. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, Clinical Therapeutics, Journal of Leukocyte Biology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.